Lineage Cell Therapeutics Inc. — Director's Dealing 2014

Jul 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2014-06-27

Reporting Person: KINGSLEY ALFRED D (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-27	Common Shares, no par value	M	50000	$2.30	Acquired	6038055	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-27	Option to Purchase Common Shares	$2.30	M	50000	Disposed	2014-07-01	Common Shares (50000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value	1627405	Indirect
Common Shares, no par value	375351	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Shares	$4.13	2018-06-30	Common Shares (50000)	50000	Direct
Option to Purchase Common Shares	$4.60	2017-06-30	Common Shares (50000)	50000	Direct
Option to Purchase Common Shares	$5.13	2016-06-30	Common Shares (50000)	50000	Direct
Option to Purchase Common Shares	$5.45	2015-08-09	Common Shares (50000)	50000	Direct

Footnotes

F1: Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.

F2: 12,500 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.

F3: 12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014.

F4: 12,500 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013.

F5: 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.

F6: 12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.